Third Quarter results confirm SPs solid position
NEW JERSEY - The finances of world-leading pharmaceutical giant Schering-Plough are very much in order. The company has recorded its 12th consecutive quarter of double-digit adjusted sales growth putting it in prime position for the integration of the Organon BioSciences portfolio and future market expansion.
23 October 2007
2 minute read
